Table 3.
Percentages of correct responses of medical students to questions on knowledge regarding Vipera palaestinae snake
| Question | Number (%) |
|---|---|
| “Vipera palaestinae is the most common venomous snake in Palestine” (T) | 125 (62.5) |
| “Its length is 1 m in average” (T) | 73 (36.5) |
| “The mortality rate due to Vipera palaestinae envenomation is 1.5%” (T) | 20 (10) |
| “Vipera palaestinae toxin contain neurotoxin compound” (T) | 107 (53.5) |
| “Vipera palaestinae toxin contain hemorrhagic compound” (T) | 45 (22.5) |
| “Vipera palaestinae toxin contain integrin inhibitors compound” (T) | 76 (38) |
| “Vipera palaestinae toxin contain cardiotoxin compound” (T) | 15 (7.5) |
| “Vipera palaestinae toxin contain growth factors inhibitors compound” (T) | 12 (6) |
| “The most frequent clinical sign of envenomation is local swelling” (T) | 93 (46.5) |
| “The most frequent clinical sign of envenomation is increased body temperature” (F) | 26 (13) |
| “Envenomation were reported only in human” (F) | 22 (11) |
| “Admission total serum cholesterol level may serve as indicator of severity of envenomation” (T) | 3 (1.5) |
| “Males are bitten twice as often as females” (T) | 74 (37) |